Business Context and Reporting Period
This Form 8-K was filed by ReWalk Robotics Ltd. (trading symbol: LFWD) on April 18, 2024. The registrant is incorporated in Israel and its ordinary shares are listed on the Nasdaq Capital Market. The filing reports a corporate governance event regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a personnel appointment and does not contain financial statement data.
Material Changes
- Board Expansion: The Board of Directors increased its size from six (6) to seven (7) members.
- New Appointment: Michael Swinford was appointed as a Class III director, effective immediately. His term will last until the 2026 annual meeting of shareholders.
- Independence: The Board determined that Mr. Swinford satisfies independence requirements under SEC rules and Nasdaq listing standards.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or management commentary regarding future performance. It details the professional background of the new director, Mr. Swinford, who brings over 30 years of healthcare experience, including serving as CEO of Numotion and holding leadership roles at GE Healthcare. His compensation will align with the standard arrangements for non-employee directors as disclosed in the Company's most recent proxy statement.
Investor Verification Checklist
- Verify the independence status of Michael Swinford against current Nasdaq listing standards.
- Review the Company's most recent Schedule 14A proxy statement to confirm the specific compensation package for non-employee directors.
- Confirm the effective date of the Board size increase and the specific class of directorship assigned.
- Check for any subsequent filings regarding committee assignments for the new director.